Free Trial

Inozyme Pharma (INZY) Institutional Ownership

Inozyme Pharma logo
$2.99 +0.18 (+6.41%)
(As of 12/20/2024 05:51 PM ET)

Institutional Ownership Changes (13F Filings) for Inozyme Pharma (NASDAQ:INZY)

Current
Institutional Ownership
Percentage
88.30%
Number of
Institutional Buyers
(last 12 months)
26
Total
Institutional Inflows
(last 12 months)
$21.94M
Number of
Institutional Sellers
(last 12 months)
9
Total
Institutional Outflows
(last 12 months)
$6.41M
Get INZY Insider Trade Alerts

Want to know when executives and insiders are buying or selling Inozyme Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

INZY Institutional Buying and Selling by Quarter

Inozyme Pharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/20/2024 Virtu Financial LLC12,309$64K0.0%N/A0.019%
11/19/2024 Barclays PLC76,730$401K0.0%+261.4%0.119%
11/16/2024 Geode Capital Management LLC1,171,172$6.13M0.0%+1.7%1.823%
11/15/2024 Barclays PLC76,730$401K0.0%+261.4%0.119%
11/15/2024 Jane Street Group LLC49,460$259K0.0%+7.5%0.077%
11/15/2024 Wellington Management Group LLP260,719$1.36M0.0%+11.9%0.406%
11/15/2024 Sphera Funds Management LTD.1,191,140$6.23M1.0%-18.6%1.854%
11/15/2024 State Street Corp1,050,420$5.49M0.0%+5.0%1.635%
11/15/2024 Readystate Asset Management LP19,049$100K0.0%N/A0.030%
11/14/2024 Eventide Asset Management LLC4,134,436$21.62M0.4%+5.0%6.436%
11/6/2024 OneDigital Investment Advisors LLC20,000$105K0.0%+51.5%0.032%
11/5/2024 GSA Capital Partners LLP35,402$185K0.0%-13.5%0.056%
10/23/2024 Values First Advisors Inc.14,695$77K0.0%-13.9%0.024%
10/3/2024 SG Americas Securities LLC15,457$81K0.0%N/A0.025%
9/16/2024 Cubist Systematic Strategies LLC18,891$84K0.0%N/A0.031%
8/15/2024 Blue Owl Capital Holdings LP1,120,027$5.00M1.4%-11.8%1.811%
8/15/2024 The Manufacturers Life Insurance Company21,427$96K0.0%+14.4%0.035%
8/15/2024 Millennium Management LLC1,787,947$7.97M0.0%+154.1%2.890%
8/15/2024 Deerfield Management Company L.P. Series C11,591$52K0.0%N/A0.019%
8/15/2024 AQR Capital Management LLC10,807$48K0.0%-61.0%0.017%
8/15/2024 Affinity Asset Advisors LLC2,856,252$12.74M1.5%+8.1%4.618%
8/14/2024 Cubist Systematic Strategies LLC18,891$84K0.0%N/A0.031%
8/14/2024 Samlyn Capital LLC3,350,535$14.94M0.2%+15.0%5.417%
8/9/2024 Renaissance Technologies LLC187,839$838K0.0%+8.1%0.304%
8/9/2024 Dimensional Fund Advisors LP380,064$1.70M0.0%+117.6%0.614%
8/8/2024 Meeder Asset Management Inc.15,210$68K0.0%N/A0.025%
8/8/2024 American Century Companies Inc.57,100$255K0.0%+11.0%0.092%
8/1/2024 Rhumbline Advisers77,004$343K0.0%+22.0%0.124%
7/26/2024 Bank of New York Mellon Corp190,896$851K0.0%+16.1%0.309%
7/19/2024 Values First Advisors Inc.17,067$76K0.0%N/A0.028%
5/16/2024 California State Teachers Retirement System4,799$37K0.0%-38.9%0.008%
5/16/2024 Kennedy Capital Management LLC437,657$3.35M0.1%+52.2%0.708%
5/15/2024 Affinity Asset Advisors LLC2,642,519$20.24M2.5%+40.1%4.272%
5/10/2024 Vanguard Group Inc.2,419,020$18.53M0.0%+1.4%3.911%
5/7/2024 SG Americas Securities LLC13,926$107K0.0%-34.4%0.023%
5/3/2024 GSA Capital Partners LLP131,098$1.00M0.1%-21.5%0.212%
2/20/2024 Eventide Asset Management LLC3,179,837$13.55M0.2%+1.8%5.149%
2/15/2024 Octagon Capital Advisors LP400,000$1.70M0.3%-69.2%0.648%
2/14/2024 Superstring Capital Management LP123,944$528K0.4%N/A0.201%
2/13/2024 Affinity Asset Advisors LLC1,885,802$8.03M1.5%+36.7%3.053%
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin
1/19/2024 Denali Advisors LLC22,000$94K0.0%-17.6%0.036%
1/18/2024 Values First Advisors Inc.13,898$59K0.0%N/A0.023%
1/12/2024 SG Americas Securities LLC21,236$90K0.0%+46.9%0.034%
11/15/2023 Rock Springs Capital Management LP3,681,174$15.46M0.4%+7.4%5.960%
11/15/2023 Laurion Capital Management LP677,329$2.85M0.0%+170.5%1.097%
11/15/2023 Adage Capital Partners GP L.L.C.5,537,500$23.26M0.1%+30.3%8.966%
11/15/2023 Affinity Asset Advisors LLC1,379,852$5.80M1.6%+83.5%2.234%
11/14/2023 Eventide Asset Management LLC3,125,000$13.13M0.2%N/A5.060%
11/14/2023 Schonfeld Strategic Advisors LLC311,880$1.31M0.0%+346.8%0.505%
11/14/2023 Pivotal bioVenture Partners Investment Advisor LLC4,494,851$18.88M7.5%+22.8%7.278%
11/13/2023CHI Advisors LLC1,270,027$5.33M1.6%+6.3%2.056%
11/13/2023 FMR LLC2,465,232$10.35M0.0%+229.2%3.992%
11/7/2023 New York State Common Retirement Fund13,375$56K0.0%-21.8%0.022%
10/26/2023 Strs Ohio9,900$41K0.0%N/A0.016%
10/13/2023 SG Americas Securities LLC14,452$61K0.0%N/A0.023%
9/21/2023 Barclays PLC10,205$56K0.0%+62.7%0.017%
8/22/2023CHI Advisors LLC1,195,027$6.66M2.0%-11.0%1.936%
8/15/2023 Sphera Funds Management LTD.1,131,967$6.31M1.0%-36.5%1.834%
8/14/2023 Deep Track Capital LP1,644,021$9.16M0.4%-49.4%2.663%
8/14/2023 Rock Springs Capital Management LP3,428,084$19.09M0.5%+6.6%5.553%
8/11/2023 Pivotal bioVenture Partners Investment Advisor LLC3,661,518$20.40M6.7%+13.9%5.932%
8/7/2023 Acadian Asset Management LLC57,468$319K0.0%N/A0.124%
8/4/2023 Parallel Advisors LLC15,427$86K0.0%-22.3%0.033%
8/4/2023 American International Group Inc.16,292$91K0.0%N/A0.035%
7/18/2023 Denali Advisors LLC26,700$149K0.1%N/A0.061%
5/15/2023 Affinity Asset Advisors LLC751,796$4.31M1.4%+50.4%1.718%
5/11/2023CHI Advisors LLC1,342,191$7.69M2.0%-39.1%3.067%
5/11/2023 Knott David M Jr160,000$917K0.4%N/A0.366%
5/1/2023 Virtu Financial LLC46,995$269K0.0%N/A0.107%
2/10/2023 NEA Management Company LLC2,437,689$2.56M0.1%-0.3%6.035%
11/14/2022 UBS Oconnor LLC165,498$444K0.0%-3.4%0.412%
8/16/2022 Deerfield Management Company L.P. Series C2,696,372$12.86M0.3%+15.0%6.724%
8/15/2022 Laurion Capital Management LP271,800$1.30M0.0%+2,618.0%0.678%
8/15/2022 Pivotal bioVenture Partners Investment Advisor LLC2,661,154$12.69M6.4%+67.2%6.637%
8/11/2022 Bioimpact Capital LLC664,980$3.17M0.9%+125.4%1.658%
8/11/2022 Overbrook Management Corp69,326$331K0.1%+314.5%0.173%
8/8/2022 Walleye Capital LLC101,442$484K0.0%N/A0.253%
2/15/2022 Laurion Capital Management LP13,390$91K0.0%-81.1%0.057%
2/15/2022 Adage Capital Partners GP L.L.C.1,599,028$10.91M0.0%+8.9%6.757%
2/14/2022 Suvretta Capital Management LLC1,013,216$6.91M0.1%+2.7%4.281%
2/11/2022 Bioimpact Capital LLC302,615$2.06M0.4%-5.6%1.279%
2/8/2022 Northern Trust Corp120,762$823K0.0%+4.0%0.510%
2/2/2022 New York State Common Retirement Fund3,834$26K0.0%-63.3%0.016%
11/16/2021 Suvretta Capital Management LLC986,400$11.43M0.2%+170.1%4.168%
11/16/2021 Wellington Management Group LLP364,600$4.23M0.0%-50.0%1.541%
11/16/2021 Laurion Capital Management LP70,700$819K0.0%N/A0.299%
11/16/2021 BioImpact Capital LLC320,724$3.72M0.6%N/A1.355%
11/16/2021CHI Advisors LLC920,264$10.67M3.1%-0.8%3.889%
11/15/2021 Deerfield Management Company L.P. Series C2,344,786$27.18M0.5%+7.6%9.910%
11/15/2021 Rock Springs Capital Management LP850,015$9.85M0.2%+1.2%3.592%
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin
11/15/2021 Marshall Wace LLP33,408$387K0.0%-16.9%0.141%
11/15/2021 Caas Capital Management LP135,398$1.57M0.0%N/A0.572%
11/12/2021 Geode Capital Management LLC198,624$2.30M0.0%+10.5%0.839%
11/8/2021 Russell Investments Group Ltd.115,516$1.34M0.0%+4,518.8%0.488%
11/2/2021 New York State Common Retirement Fund10,453$121K0.0%+18.8%0.044%
11/1/2021 SG Americas Securities LLC11,611$135K0.0%N/A0.049%
8/25/2021 Marshall Wace LLP40,202$685K0.0%-22.4%0.170%
8/17/2021 Millennium Management LLC61,313$1.05M0.0%-58.9%0.259%
8/17/2021Burrage Capital Management LLC242,517$4.13M4.1%+43.1%1.025%
8/17/2021 Citadel Advisors LLC171,066$2.92M0.0%-28.8%0.723%
(Data available from 1/1/2016 forward)

INZY Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of INZY shares?

During the previous two years, 48 institutional investors and hedge funds held shares of Inozyme Pharma. The most heavily invested institutionals were Adage Capital Partners GP L.L.C. ($23.26M), Eventide Asset Management LLC ($21.62M), Pivotal bioVenture Partners Investment Advisor LLC ($18.88M), Vanguard Group Inc. ($18.53M), Rock Springs Capital Management LP ($15.46M), Samlyn Capital LLC ($14.94M), and Affinity Asset Advisors LLC ($12.74M).Learn more on INZY's institutional investors.

What percentage of Inozyme Pharma stock is owned by institutional investors?

88.30% of Inozyme Pharma stock is owned by institutional investors. Learn more on INZY's institutional investor holdings.

Which institutional investors have been buying Inozyme Pharma stock?

Of the 38 institutional investors that purchased Inozyme Pharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Eventide Asset Management LLC ($3.38M), Affinity Asset Advisors LLC ($2.36M), FMR LLC ($1.72M), Adage Capital Partners GP L.L.C. ($1.29M), Pivotal bioVenture Partners Investment Advisor LLC ($1.28M), Millennium Management LLC ($1.08M), and Rock Springs Capital Management LP ($466.27K).

How much institutional buying is happening at Inozyme Pharma?

Institutional investors have bought a total of 14,031,805 shares in the last 24 months. This purchase volume represents approximately $65.00M in transactions.

Which Inozyme Pharma major shareholders have been selling company stock?

Of the 14 institutional investors that sold Inozyme Pharma stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Deep Track Capital LP ($1.61M), CHI Advisors LLC ($1.01M), Sphera Funds Management LTD. ($921.48K), Octagon Capital Advisors LP ($900K), Blue Owl Capital Holdings LP ($150K), GSA Capital Partners LLP ($41.44K), and AQR Capital Management LLC ($16.91K).

How much institutional selling is happening at Inozyme Pharma?

Institutional investors have sold a total of 4,677,943 shares in the last 24 months. This volume of shares sold represents approximately $24.79M in transactions.



This page (NASDAQ:INZY) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners